<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="168249">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02013999</url>
  </required_header>
  <id_info>
    <org_study_id>B-1306/208-005</org_study_id>
    <nct_id>NCT02013999</nct_id>
  </id_info>
  <brief_title>The Development of Upper Extremity Rehabilitation Program Using Virtual Reality for the Stroke Patients</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Bundang Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Seoul National University Bundang Hospital</source>
  <oversight_info>
    <authority>Korea: Institutional Review Board</authority>
  </oversight_info>
  <brief_summary>
    <textblock>
      Using the upper extremity rehabilitation program developed by virtual reality would help the
      recovery upper extremity function in patients with stroke.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>October 2013</start_date>
  <primary_completion_date type="Anticipated">December 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Fugl-Meyer upper extremity scale</measure>
    <time_frame>baseline(just before beginning the treatment), at the end of the treatment for 2 weeks, 1 month later of the end of the treatment for 2 weeks</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>brunnstr√∂m stage</measure>
    <time_frame>baseline(just before beginning the treatment), at the end of the treatment for 2 weeks, 1 month later of the end of the treatment for 2 weeks</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Modified Barthel Index</measure>
    <time_frame>baseline(just before beginning the treatment), at the end of the treatment for 2 weeks, 1 month later of the end of the treatment for 2 weeks</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Medical Research Council (MRC) Scale for Muscle Strength</measure>
    <time_frame>baseline(just before beginning the treatment), at the end of the treatment for 2 weeks, 1 month later of the end of the treatment for 2 weeks</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Euroqol(EQ)-5D</measure>
    <time_frame>baseline(just before beginning the treatment), at the end of the treatment for 2 weeks, 1 month later of the end of the treatment for 2 weeks</time_frame>
    <safety_issue>No</safety_issue>
    <description>EQ-5D</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Virtual reality kinematic data</measure>
    <time_frame>everytime when the patient uses program (automatically all recorded)</time_frame>
    <safety_issue>No</safety_issue>
    <description>Automatically recorded</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>questionnaire</measure>
    <time_frame>at the end of the treatment for 2 weeks</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Upper Extremity Dysfunction After the Stroke</condition>
  <arm_group>
    <arm_group_label>Virtual reality program</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>mobile device for virtual reality program</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>standard occupuational therapy</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Virtual reality program for upper extremity rehabilitation</intervention_name>
    <arm_group_label>Virtual reality program</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>standard occupational therapy</intervention_name>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  ischemic or hemorrhagic stroke confirmed by brain imaging study

          -  upper extremity dysfunction

          -  possible to use a simple device

        Exclusion Criteria:

          -  delirium, confusion or other evidence related to the consciousness

          -  uncontrolled medical or surgical disease

          -  unable to command to the order due to severe cognitive impairment

          -  visual impairment

          -  unable to sit
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Seoul National University Bundang Hospital</name>
      <address>
        <city>SungNam</city>
        <state>KyungKi</state>
        <zip>463-707</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nam-Jong Paik, Professor</last_name>
      <phone>82-31-787-7731</phone>
      <phone_ext>7731</phone_ext>
      <email>njpaik@snu.ac.kr</email>
    </contact>
    <investigator>
      <last_name>Nam-Jong Paik, Professor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>December 2013</verification_date>
  <lastchanged_date>December 11, 2013</lastchanged_date>
  <firstreceived_date>December 3, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Seoul National University Bundang Hospital</investigator_affiliation>
    <investigator_full_name>Nam-Jong Paik</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Stroke</mesh_term>
    <mesh_term>Cerebral Infarction</mesh_term>
    <mesh_term>Musculoskeletal Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
